SCHOFIELD, Wis., Sept. 20, 2011 (GLOBE NEWSWIRE) -- PuraMed BioScience, Inc. (OTCQB:PMBS) announced today that they have received the initial series of purchase orders with one of the top retailers in the United States to carry its new non-prescription migraine medication, LipiGesic™ M. These purchase orders will allow the company to achieve national distribution for the first time. The Company expects to commence shipment of its product to the retailer's warehouses no later than October 1, 2011 and anticipates that it will be available at thousands of retail stores nationwide in early November. PuraMed will continue to sell LipiGesic™ M on the Company's website, www.lipigesic.com.
"This national distribution represents a major milestone for PuraMed as it allows us easy access to millions of migraine sufferers nationwide which will provide us with significant revenue moving forward," said Russ Mitchell, CEO of PuraMed BioScience, Inc. Mitchell added, "We continue to have discussions and actively pursue other retail distribution opportunities worldwide."
In addition to the retail launch of LipiGesic™ M, PuraMed BioScience recently announced that three top headache researchers performed a study of LipiGesic™ M that was published in the top-tier medical journal, Headache. This study demonstrated that the product was highly effective and recommended LipiGesic™ M as a first line treatment for migraines to the medical community.
PuraMed BioScience, Inc. plans to provide more information as it becomes available.
About the PuraMed BioScience, Inc.:
PuraMed BioScience, Inc. engages in the research, development and marketing of non-prescription medicinal and healthcare products. In addition to its leading product LipiGesic™ M, which provides acute relief from migraine headaches; the Company also has plans to launch LipiGesic™ PM that provides a remedy for insomnia and other sleep disorders as well as LipiGesic™ H for common tension headaches. For more information on PuraMed, visit the Company website at www.PuraMedBioScience.com, join the Company's group page on Facebook by searching "PuraMed BioScience".
Forward-Looking Statements:
This news release contains forward-looking statements regarding PuraMed BioScience and its future business plans, which statements involve known and unknown risks and uncertainties. Such risks and uncertainties may cause actual results and future achievements of PuraMed BioScience to be materially different than those implied by these forward-looking statements. PuraMed BioScience has and undertakes no obligation to provide public updates and revisions to these forward-looking statements to reflect any changes in its expectations of future events.